Skip to main navigation Skip to search Skip to main content

Short- and intermediate-term survival after extracorporeal membrane oxygenation in children with cardiac disease

  • Constantinos Chrysostomou
  • , Victor O. Morell
  • , Bradley A. Kuch
  • , Elizabeth O'Malley
  • , Ricardo Munoz
  • , Peter D. Wearden
  • University of Pittsburgh

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

Objectives: In children with cardiac disease, common indications for extracorporeal membrane oxygenation (ECMO) include refractory cardiopulmonary resuscitation (E-CPR), failure to separate from cardiopulmonary bypass (OR-ECMO), and low cardiac output syndrome (LCOS-ECMO). Despite established acceptance, ECMO outcomes are suboptimal with a survival between 38% and 55%. We evaluated factors associated with significantly increased survival in cardiac patients requiring ECMO. Methods: We conducted a retrospective investigation of consecutive patients undergoing ECMO between 2006 and 2010. Demographic, pre-ECMO, ECMO, and post-ECMO parameters were analyzed. Neurologic outcomes were assessed with the pediatric overall performance category scale at the latest follow-up. Results: There were 3524 admissions, 95 (3%) of which necessitated ECMO; 40 (42%) E-CPR, 31 (33%) OR-ECMO, and 24 (25%) LCOS-ECMO. The overall hospital survival was 73%. The within-groups hospital survival was 75% in E-CPR, 77% OR-ECMO and 62% LCOS-ECMO. In the multivariable logistic regression analysis, chromosomal anomalies (odds ratio [OR], 8; 95% confidence interval [CI], 2-35), single ventricle (OR,6; 95% CI, 3-33), multiple ECMO runs (OR, 15; 95% CI, 4-42), higher 24-hour ECMO flows (OR, 8; 95% CI, 4-22), decreased lung compliance (OR, 5; 95% CI, 2-16), and need for plasma exchange (OR, 5; 95% CI, 3-18) were all significant factors associated with mortality. From the univariate analysis, a common parameter associated with mortality within all groups was intracranial hemorrhage. At 1.9 years (0.9, 2.9) of follow-up, 66% were still alive, and 89% of survivors had normal function or only mild neurodevelopmental disability. Conclusions: ECMO was successfully used in children with cardiac disease with 73% and 66% short- and intermediate-term survival, respectively. The majority of the survivors had normal function or only a minimal neurodevelopmental deficit.

Original languageEnglish
Pages (from-to)317-325
Number of pages9
JournalJournal of Thoracic and Cardiovascular Surgery
Volume146
Issue number2
DOIs
StatePublished - Aug 2013
Externally publishedYes

Keywords

  • ACT
  • APTT
  • CI
  • CPB
  • CPR
  • E-CPR
  • ECMO
  • LCOS
  • OR
  • OR-ECMO
  • POPC
  • Pediatric Overall Performance Category
  • VAD
  • activated clotting time
  • activated partial thromboplastin time
  • cardiopulmonary bypass
  • cardiopulmonary resuscitation
  • confidence interval
  • extracorporeal membrane oxygenation
  • failure to separate from cardiopulmonary bypass in the operating room
  • low cardiac output syndrome
  • odds ratio
  • refractory cardiopulmonary resuscitation
  • ventricular assist device

Fingerprint

Dive into the research topics of 'Short- and intermediate-term survival after extracorporeal membrane oxygenation in children with cardiac disease'. Together they form a unique fingerprint.

Cite this